PrimeRFP SCOUT · Federal Contract Recompete Brief

75D30123P17556CBTRUS - malignant and non-malignant TUMORS — Central Brain Tumor Registry of the United States

Central Brain Tumor Registry of the United States holds $145K across 3 federal awards, concentrated at Department of Health and Human Services (HHS). The prior award was single-bid — competitive dynamics may favor a challenge. Set-aside status: NONE. Recompete timing centers on the Sep 29, 2027 PoP end — agencies typically plan 12–18 months ahead.

Cdc Office Of Acquisition Services

Awarding office

Central Brain Tumor Registry of the United States

Recipient

Sep 29, 2027

PoP end

$180K

Obligated

$240K

Potential

518210

NAICS

B529

PSC

NONE

Set-aside

1 bidders on last award

Watch this recompete

One email. No account. We ping you if the window moves.

Score my position vs Central Brain Tumor Registry of the United States — $90

Contract facts

NONE

Contract number75D30123P17556

AgencyCdc Office Of Acquisition Services

Awarding officeCdc Office Of Acquisition Services

Awarding agencyDepartment of Health and Human Services (HHS)

Funding agencyDepartment of Health and Human Services (HHS)

IncumbentCentral Brain Tumor Registry of the United States

CAGE3K3C0

UEIDN9HX97KL5R5

NAICS518210

No full NAICS 518210 intel page yet. Browse NAICS intelligence

PSCB529

Place of performanceHINSDALE IL

Pricing typeFirm Fixed Price

Extent competedNot Competed Under SAP

Related solicitation75D301-23-Q-76757

PoP startSep 30, 2023

PoP end (current)Sep 29, 2027

Obligated$180K

Current value$240K

Potential value$240K

CBTRUS - MALIGNANT AND NON-MALIGNANT TUMORS is a federal NONE award for Cdc Office Of Acquisition Services held by Central Brain Tumor Registry of the United States. Estimated value $240K ($180K obligated). Current period of performance ends Sep 29, 2027. Last award drew 1 bidder. Place of performance: HINSDALE IL. Related solicitation 75D301-23-Q-76757.

CBTRUS - MALIGNANT AND NON-MALIGNANT TUMORS

Recompete timing

Public

● Expiring in 405 days

Current PoP ends Sep 29, 2027 (405 days remaining). Agencies typically plan 12–18 months ahead — position before the PoP clock runs out.

Incumbent footprint

Public record

Central Brain Tumor Registry of the United States — $145K obligated across 3 awards (firm-wide, all agencies).

Sole agency: Department of Health and Human Services (HHS)

Department of Health and Human Services (HHS)$145K · 100% of firm total

Open full company profile →

Query this award live in SCOUT via MCP — personalized scoring, watchlists, and capture workflow across the corpus. Learn about SCOUT MCP →

Frequently asked questions

What is contract 75D30123P17556?

75D30123P17556 (CBTRUS - malignant and non-malignant TUMORS) is a Cdc Office Of Acquisition Services award with a potential value of $240K, currently held by Central Brain Tumor Registry of the United States. Figures are USASpending-sourced public-record facts plus SCOUT recompete analysis.

Which office awarded 75D30123P17556?

Cdc Office Of Acquisition Services awarded 75D30123P17556 to Central Brain Tumor Registry of the United States (potential $240K).

Who is the incumbent on 75D30123P17556?

Central Brain Tumor Registry of the United States is the incumbent with $145K across 3 related awards in SCOUT’s public footprint. The current period of performance ends Sep 29, 2027.

When does Central Brain Tumor Registry of the United States’s 75D30123P17556 come up for recompete?

SCOUT tracks a period-of-performance end of Sep 29, 2027. Actual solicitation timing can shift with extensions, bridges, or consolidations.

Data: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows.

Data as of Aug 19, 2026 · refreshed monthlyLatest procurement action Jun 4, 2026